{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "8627602", "DateCompleted": {"Year": "1996", "Month": "06", "Day": "25"}, "DateRevised": {"Year": "2007", "Month": "11", "Day": "14"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0022-2623", "JournalIssue": {"Volume": "39", "Issue": "9", "PubDate": {"Year": "1996", "Month": "Apr", "Day": "26"}}, "Title": "Journal of medicinal chemistry", "ISOAbbreviation": "J Med Chem"}, "ArticleTitle": "Longimicins A-D: novel bioactive acetogenins from Asimina longifolia (annonaceae) and structure-activity relationships of asimicin type of annonaceous acetogenins.", "Pagination": {"StartPage": "1790", "EndPage": "1796", "MedlinePgn": "1790-6"}, "Abstract": {"AbstractText": ["Bioactivity-directed fractionation of the ethanol extract of Asimina longifolia led to the isolation of four novel bioactive annonaceous acetogenins: longimicins A-D (1-4). Compounds 1-4 represent the asimicin type of acetogenins; however, the locations of the adjacent bis-tetrahydrofuran (THF) ring moieties are shifted along the aliphatic chains compared to the known compounds of this type. They are the first examples among this type of acetogenins with the placements of the ring systems altered. Compounds 1-4 showed bioactivities in several bioassays, but they are less active than their structural isomers. Study of their structure-activity relationships (SAR) reveals that the position of the adjacent bis-THF ring moiety is essential for maximization of the bioactivities among these asimicin type annonaceous acetogenins."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, Indiana 47907, USA."}], "LastName": "Ye", "ForeName": "Q", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "He", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Oberlies", "ForeName": "N H", "Initials": "NH"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Zeng", "ForeName": "L", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Shi", "ForeName": "G", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Evert", "ForeName": "D", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "McLaughlin", "ForeName": "J L", "Initials": "JL"}], "GrantList": [{"GrantID": "R01 CA 30909", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Med Chem", "NlmUniqueID": "9716531", "ISSNLinking": "0022-2623"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Furans"}, {"RegistryNumber": "102989-24-2", "NameOfSubstance": "bullatacin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Furans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants"}, {"QualifierName": [], "DescriptorName": "Spectrum Analysis"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1996", "Month": "4", "Day": "26"}, {"Year": "1996", "Month": "4", "Day": "26", "Hour": "0", "Minute": "1"}, {"Year": "1996", "Month": "4", "Day": "26", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8627602", "10.1021/jm9600510", "jm9600510"]}}]}